Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines flag Philippines · Delayed Price · Currency is PHP
1.370
+0.100 (7.87%)
At close: Nov 17, 2026

PSE:EURO Cash Flow Statement

Millions PHP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
525.88470.3337.68289.95199.89169.05
Depreciation & Amortization
308.51398.89329.59298.23286.89278.33
Loss (Gain) From Sale of Assets
---36.45---
Loss (Gain) From Sale of Investments
-45.64-45.64-22.47-13.231.09-43.93
Provision & Write-off of Bad Debts
8.18.116.863.694.2513.17
Other Operating Activities
76.5162.97-17.2327.2319.6114.88
Change in Accounts Receivable
118.05-58.11-316.16-187.32-64.71211.04
Change in Inventory
62.87159.29-48.89-156.16-272.43132.05
Change in Accounts Payable
38.79-56.72-94.29167.6328.74-353.51
Change in Other Net Operating Assets
35.5231.6498.17-75.9-55.0967.33
Operating Cash Flow
1,129970.72246.81354.13148.23488.4
Operating Cash Flow Growth
131.12%293.31%-30.30%138.90%-69.65%10.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-208.02-267.93-196.08-291.87-88.89-285.57
Sale of Property, Plant & Equipment
--43.14---
Sale (Purchase) of Intangibles
-2-2----
Investment in Securities
-28.66-28.66---72.85
Investing Cash Flow
-238.69-298.6-152.94-291.87-88.89-212.72

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,1393,1353,4782,3991,884
Long-Term Debt Issued
-330209.79309.764598.8
Total Debt Issued
2,9053,4693,3453,7882,4632,483
Short-Term Debt Repaid
--3,181-3,109-3,097-2,049-2,243
Long-Term Debt Repaid
--323.99-107.37-349.5-271.96-475
Lease Payments
-86.31-86.31-80.82-68.53-72.05-46.51
Total Debt Repaid
-2,870-3,505-3,216-3,447-2,321-2,718
Net Debt Issued (Repaid)
34.44-36.16128.62341.32142.36-235.68
Common Dividends Paid
-287.85-287.85-246.73-143.92-143.92-
Financing Cash Flow
-253.41-324.01-118.11197.39-1.56-235.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.020.020.515.983.436.08
Net Cash Flow
560.13348.13-23.73265.6361.2146.09

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
920.57702.7850.7362.2659.35202.83
Free Cash Flow Growth
272.69%1285.29%-18.52%4.91%-70.74%-
Free Cash Flow Margin
12.90%10.23%0.88%1.18%1.41%5.65%
Free Cash Flow Per Share
0.220.170.010.010.010.05
Levered Free Cash Flow
842.15592.2365.152.47-57.12123.61
Unlevered Free Cash Flow
936.38780.16257.52171.572.13256.85
Free Cash Flow After Leases
834.26616.47-30.09-6.28-12.71156.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
64.95289.55295.57261196.45206.8
Cash Income Tax Paid
79.41137.37140.3895.0468.8986.43
Change in Working Capital
255.2376.1-361.17-251.74-363.556.91